Terry, it makes little sense for you to claim that the reason for a decline from 30 to 4 based on no bad news is due to the market's lack of knowledge/faith in a new approach (a Listeria vaccine). And if you dispute that clinical biotechs in general--and ADXS in particular--are widely shorted and manipulated then I'm afraid you are missing something.